期刊文献+

利普刀治疗宫颈疾病58例临床观察 被引量:1

Clinical Observation on Treatment of 58 Cases of Cervical Disease by LEEP
下载PDF
导出
摘要 目的探讨利普刀治疗宫颈疾病的临床价值。方法对58例宫颈疾病患者将利普刀治疗的29例患者分为观察组,将药物治疗的29例患者分为对照组。观察两组患者的手术时间、术中出血量、手术效果、复发率。结果观察组平均手术时间短,手术出血量少。观察组总有效率高于对照组,观察组复发率低于对照组,差异具有统计学意义(P<0.05)。结论对宫颈疾病患者采用利普刀治疗具有出血量少、手术院时间短、治愈率高、复发率低的优点。 Objective To explore the effect of Leep treatment for cervical disease. Methods 58 cases of cervical disease LEEP in the treatment of 29 cases of patients were divided into observation group, the drug treatment of 29 cases of patients were divided into the control group. The operation time, intraoperative blood loss, operative effect and recurrence rate of the two groups were observed. Results Observation group average surgery time is short, less blood loss. total effective observation group was obviously higher than that of control group and observation group recurrence rates significantly lower than the control group, the difference is statistically significant(P〈0.05). Conclusion For cervical disease patients, Leep treatment has mini trauma, less blood less, shorter hospital time, high valueable, lower recurrence rate.
作者 姚桂华
出处 《中国继续医学教育》 2016年第7期120-121,共2页 China Continuing Medical Education
关键词 利普刀 宫颈疾病 临床效果 Leep Cervical disease Effect
  • 相关文献

参考文献9

二级参考文献49

  • 1金凤斌,白碧玲.宫颈电圈切除术治疗慢性宫颈炎62例临床观察[J].中国实用妇科与产科杂志,2004,20(8):494-494. 被引量:31
  • 2卢晓声,郑伟.宫颈环形电切术对妊娠影响的研究进展[J].中国实用妇科与产科杂志,2007,23(3):227-229. 被引量:89
  • 3Kietpeerakool C, SrisomboonJ, Ratchusiri K. Clinicopathologicpre - dictord of incomplete excision after loop electrosurgical excision for cerv ieal preneoplasia[J]. Asian Pac J Cancer Prey, 2005,6 (4) :481 -484.
  • 4曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2004.2170-2172.
  • 5关铮.微创妇科学.北京:人民军医出版社,2005:345—346.
  • 6姚守润,何海燕.高原地区利普刀治疗慢性宫颈炎的疗效观察[J].中国健康月刊(学术版),2010,29(3):10-11.
  • 7卡美璐,刘晓华.高频电刀用于宫颈病变诊断治疗的临床观察[J].中华妇产科杂志,2011,35(3):160.
  • 8汤礼宾.微波与力普刀治疗宫颈糜烂120例临床分析研究[J].医药前沿,2012(2):197-198.
  • 9樊庆泊,朗景和.子宫颈环形电切操作在宫颈上皮类瘤变诊治方面的应用[J].现代妇产科应用杂志,2009,11(14):472-473.
  • 10He E, Xu XH, Guan H, et al. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma[J]. Nucleosides Nucleotides Nucleic Acids, 2010, 29(4/6):352-358.

共引文献40

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部